RVL Pharmaceuticals plc Partners' Capital
RVL Pharmaceuticals plc had Partners' Capital of $427.21 million as of 2018-10-17, per its 10-K filed 2020-03-19.
Discontinued › Balance Sheet › Equity › Partners' Capital
us-gaap:PartnersCapital · last filed 2020-03-19
- 2018-10-17: Partners' Capital $427.21M; Partners' Capital as first filed $429.87M.
- 2018-09-30: Partners' Capital $430.78M; Partners' Capital as first filed $415.50M.
- 2018-06-30: Partners' Capital $434.53M; Partners' Capital as first filed $437.02M.
- 2018-03-31: Partners' Capital $429.54M; Partners' Capital as first filed $431.85M.
| Period end | Partners' Capital | Partners' Capital as first filed |
|---|---|---|
| 2018-10-17 | $427.21M 10-K · filed 2020-03-19 | $429.87M 10-K · filed 2019-03-28 |
| 2018-09-30 | $430.78M 10-Q · filed 2019-11-14 | $415.50M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $434.53M 10-Q · filed 2019-11-14 | $437.02M 10-Q · filed 2019-08-08 |
| 2018-03-31 | $429.54M 10-Q · filed 2019-11-14 | $431.85M 10-Q · filed 2019-05-09 |
| 2017-12-31 | $433.65M 10-K · filed 2020-03-19 | $419.27M 10-Q · filed 2018-11-08 |
| 2016-12-31 | $475.68M 8-K · filed 2019-12-20 | $477.71M 10-K · filed 2019-03-28 |